Doctor profile · Federal record
Dr. Steven Golombek, M.D.
Rheumatology Physician (CMS: Rheumatology) · Dover, NJ
- NPI 1760449565
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 45 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
600 Mount Pleasant Ave, Suite C
Dover, NJ 078011629
(973) 989-0500
fax (973) 989-5046
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- November 26, 2007
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- New Jersey #470680
- Medicaid
- NJ #3039706
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760449565. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
419,341
Distinct HCPCS
10
Medicare allowed
$5,324,083
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 181,800 | 78 | $5 | |
J3262 |
Injection, tocilizumab, 1 mg | 118,880 | 33 | $6 | |
J0897 |
Injection, denosumab, 1 mg | 42,360 | 424 | $23 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 17,640 | 18 | $10 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 16,985 | 40 | $42 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 14,200 | 28 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 8,310 | 39 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 2,816 | 1,023 | $138 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 2,381 | 543 | $83 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 2,190 | 31 | $45 |
In context: peer comparison
Among 1 peers in Dover Rheumatology Physician, average services per provider: 11,333. This provider delivers 37× the peer median.Open Payments
Industry payments received
All-time total
$31,636
Transactions
76
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 36 | $20,699.41 | |
| AstraZeneca Pharmaceuticals Lp | 12 | $10,501.36 | |
| Novartis Pharmaceuticals Corporation | 16 | $239.83 | |
| Ucb, INC. | 6 | $93.39 | |
| Fresenius Kabi USA, LLC | 3 | $49.30 | |
| Ani Pharmaceuticals, INC. | 1 | $18.90 | |
| Pfizer INC. | 1 | $18.28 | |
| Genentech USA, INC. | 1 | $15.59 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,993
Patients
753
Total drug cost
$58,949
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 834 | 243 | $7,303 |
| Methotrexate (Methotrexate Sodium) | Brand | 759 | 167 | $21,028 |
| Gabapentin | Generic | 248 | 50 | $3,565 |
| Tramadol Hcl | Generic | 170 | 26 | $1,062 |
| Hydroxychloroquine Sulfate | Generic | 159 | 39 | $12,350 |
| Allopurinol | Generic | 157 | 40 | $2,543 |
| Meloxicam | Generic | 135 | 63 | $845 |
| Duloxetine Hcl | Generic | 123 | 30 | $4,706 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 72 | 12 | $1,144 |
| Folic Acid | Generic | 63 | 21 | $279 |
Hospital affiliations
Frequently asked questions
What is Dr. Steven Golombek's medical specialty?
Dr. Steven Golombek practices Rheumatology Physician in Dover, NJ.
Where does Dr. Steven Golombek practice?
Dr. Steven Golombek practices at 600 Mount Pleasant Ave, Dover, NJ 078011629. Office phone: 9739890500.
What is Dr. Steven Golombek's NPI?
Dr. Steven Golombek's National Provider Identifier (NPI) is 1760449565, issued by NPPES.
Does Dr. Steven Golombek accept Medicare assignment?
Yes. Dr. Steven Golombek accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Steven Golombek commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.